Reward deficiency syndrome: genetic aspects of behavioral disorders
The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called ‘natural rewards’ and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same releas...
Saved in:
Published in | Progress in Brain Research Vol. 126; pp. 325 - 341 |
---|---|
Main Authors | , |
Format | Book Chapter Journal Article |
Language | English |
Published |
Netherlands
Elsevier Science & Technology
2000
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called ‘natural rewards’ and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by ‘unnatural rewards’ such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compuslive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. |
---|---|
AbstractList | The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called 'natural rewards' and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by 'unnatural rewards' such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compulsive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. However, serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons all modify dopamine metabolism and dopamine neurons. We have proposed that defects in various combinations of the genes for these neurotransmitters result in a Reward Deficiency Syndrome (RDS) and that such individuals are at risk for abuse of the unnatural rewards. Because of its importance, the gene for the [figure: see text] dopamine D2 receptor was a major candidate gene. Studies in the past decade have shown that in various subject groups the Taq I A1 allele of the DRD2 gene is associated with alcoholism, drug abuse, smoking, obesity, compulsive gambling, and several personality traits. A range of other dopamine, opioid, cannabinoid, norepinephrine, and related genes have since been added to the list. Like other behavioral disorders, these are polygenically inherited and each gene accounts for only a small per cent of the variance. Techniques such as the Multivariate Analysis of Associations, which simultaneously examine the contribution of multiple genes, hold promise for understanding the genetic make up of polygenic disorders. The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called 'natural rewards' and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by 'unnatural rewards' such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compulsive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. However, serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons all modify dopamine metabolism and dopamine neurons. We have proposed that defects in various combinations of the genes for these neurotransmitters result in a Reward Deficiency Syndrome (RDS) and that such individuals are at risk for abuse of the unnatural rewards. Because of its importance, the gene for the [figure: see text] dopamine D2 receptor was a major candidate gene. Studies in the past decade have shown that in various subject groups the Taq I A1 allele of the DRD2 gene is associated with alcoholism, drug abuse, smoking, obesity, compulsive gambling, and several personality traits. A range of other dopamine, opioid, cannabinoid, norepinephrine, and related genes have since been added to the list. Like other behavioral disorders, these are polygenically inherited and each gene accounts for only a small per cent of the variance. Techniques such as the Multivariate Analysis of Associations, which simultaneously examine the contribution of multiple genes, hold promise for understanding the genetic make up of polygenic disorders.The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called 'natural rewards' and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by 'unnatural rewards' such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compulsive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. However, serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons all modify dopamine metabolism and dopamine neurons. We have proposed that defects in various combinations of the genes for these neurotransmitters result in a Reward Deficiency Syndrome (RDS) and that such individuals are at risk for abuse of the unnatural rewards. Because of its importance, the gene for the [figure: see text] dopamine D2 receptor was a major candidate gene. Studies in the past decade have shown that in various subject groups the Taq I A1 allele of the DRD2 gene is associated with alcoholism, drug abuse, smoking, obesity, compulsive gambling, and several personality traits. A range of other dopamine, opioid, cannabinoid, norepinephrine, and related genes have since been added to the list. Like other behavioral disorders, these are polygenically inherited and each gene accounts for only a small per cent of the variance. Techniques such as the Multivariate Analysis of Associations, which simultaneously examine the contribution of multiple genes, hold promise for understanding the genetic make up of polygenic disorders. The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called ‘natural rewards’ and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by ‘unnatural rewards’ such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compuslive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. |
Author | Comings, David E. Blum, Kenneth |
Author_xml | – sequence: 1 givenname: David E. surname: Comings fullname: Comings, David E. email: dcomings@earthlink.net organization: Department of Medical Genetics, City of Hope Medical Center, Duarte, CA 91010, USA – sequence: 2 givenname: Kenneth surname: Blum fullname: Blum, Kenneth organization: Department of Biological Sciences, University of North Texas, Denton TX 76203 and Department of Clinical Sciences, PATH Medical Foundation, New York, NY, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11105655$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kMlOwzAQQC0oogv9BFBOCA6BsR07CReEKjapEhLL2XLsCRhlKXZa1L8nLYXTXN6M5r0xGTRtg4QcU7igQOXlC0Cax5IyfgZwziQwFss9MqJZKuI0E2KfTPM0gyRJBHDO8gEZ_a8MyTiETwCW5pAckiGlFIQUYkRmz_itvY0sls44bMw6CuvG-rbGq-gdG-yciXRYoOlC1JZRgR965Vqvq8i60HqLPhyRg1JXAae7OSFvd7evs4d4_nT_OLuZx8gk72Jt0SYl17IUUgMgz1LOrDGQacw0LwwrUWfALDMFyIIClqVMtC2yXIIUmk_I6e_dhW-_lhg6VbtgsKp0g-0yqJQlggvGe_BkBy6LGq1aeFdrv1Z_2j1w_Qtg_-7KoVdhK4_W-d5U2dYpCmoTXm3Dq01FBaC24ZXkP1GNdFk |
ContentType | Book Chapter Journal Article |
Copyright | 2000 |
Copyright_xml | – notice: 2000 |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/S0079-6123(00)26022-6 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1875-7855 |
EndPage | 341 |
ExternalDocumentID | 11105655 S0079612300260226 |
Genre | Journal Article Review |
GroupedDBID | --- --K -~X .55 0R~ 123 3O- 53G 5RE 8NA 8NC 8NF AAPMF AAXUO AAYSV ABGWT ABMAC ABQQC ACGFS ACXMD AENEX AFFNX AFOST AFTJW AGAMA AHPSJ ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF DU5 EBS EJD F5P FDB FEDTE HVGLF HZ~ JDP L7B O9- P2P RIG SBF SDK SES SHL X7M ZGI ZXP AALRI ADVLN AHMUE AKRWK CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-e263t-aded4f3a6f56a00e38732dcc08ae8a3bc2fea802d2cb06b10eff64adb896065a3 |
ISBN | 9780444503329 0444503323 |
ISSN | 0079-6123 |
IngestDate | Fri Jul 11 04:35:22 EDT 2025 Sat Sep 28 07:34:59 EDT 2024 Fri Feb 23 02:34:14 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-e263t-aded4f3a6f56a00e38732dcc08ae8a3bc2fea802d2cb06b10eff64adb896065a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 11105655 |
PQID | 72453523 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_72453523 pubmed_primary_11105655 elsevier_sciencedirect_doi_10_1016_S0079_6123_00_26022_6 |
PublicationCentury | 2000 |
PublicationDate | 2000 2000-00-00 20000101 |
PublicationDateYYYYMMDD | 2000-01-01 |
PublicationDate_xml | – year: 2000 text: 2000 |
PublicationDecade | 2000 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Progress in Brain Research |
PublicationTitleAlternate | Prog Brain Res |
PublicationYear | 2000 |
Publisher | Elsevier Science & Technology |
Publisher_xml | – name: Elsevier Science & Technology |
SSID | ssj0027904 ssj0000782502 |
Score | 2.1953442 |
SecondaryResourceType | review_article |
Snippet | The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and... The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and... |
SourceID | proquest pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 325 |
SubjectTerms | Attention Deficit Disorder with Hyperactivity - genetics Behavior, Addictive - genetics Carrier Proteins - genetics Carrier Proteins - physiology Central Nervous System Stimulants - pharmacology Compulsive Behavior - genetics Dangerous Behavior Dopamine beta-Hydroxylase - genetics Exploratory Behavior Genetic Heterogeneity Genetic Predisposition to Disease Humans Impulsive Behavior - genetics Models, Neurological Monoamine Oxidase - genetics Neurotransmitter Agents - metabolism Neurotransmitter Agents - physiology Nucleus Accumbens - drug effects Nucleus Accumbens - physiology Opioid Peptides - genetics Opioid Peptides - physiology Polymorphism, Restriction Fragment Length Prefrontal Cortex - drug effects Prefrontal Cortex - physiology Receptors, Adrenergic - drug effects Receptors, Adrenergic - genetics Receptors, Cannabinoid Receptors, Dopamine D2 - drug effects Receptors, Dopamine D2 - genetics Receptors, Dopamine D2 - physiology Receptors, Dopamine D4 Receptors, Drug - drug effects Receptors, Drug - genetics Receptors, Neurotransmitter - drug effects Receptors, Neurotransmitter - genetics Receptors, Neurotransmitter - physiology Reward Satiation - physiology Self Stimulation - physiology Stress Disorders, Post-Traumatic - genetics Stress Disorders, Post-Traumatic - physiopathology Substance-Related Disorders - genetics Tourette Syndrome - genetics Tourette Syndrome - physiopathology |
Title | Reward deficiency syndrome: genetic aspects of behavioral disorders |
URI | https://dx.doi.org/10.1016/S0079-6123(00)26022-6 https://www.ncbi.nlm.nih.gov/pubmed/11105655 https://www.proquest.com/docview/72453523 |
Volume | 126 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2ywVxKZTH8vQBIVCV4rUTx8ttVbWqqOBQWtqb5cSOxKEJotkD_HpmbMfZXeBAL9lVFG3smdnxfOOZz4S8xs02WwiZgaurstywPDMCwcqchxMh5373_NNneXKRf7wqriaTZq1qadVXB_Wvv_aV3EarcA_0il2y_6HZ9KNwA76DfuEKGobrVvC7mWYNpBdYWYV-6lsLGgKAn6ro0r5Cd4158FS6vn90kNB3PN84tuWsG86Zw0LafeuQW8I3Zg6sBpg9gOE4z_HqWzR9Hchap7-NXJ6byQS2lUxIXS6DY0Hz28rxD9gTieZwDzQmLKJ_LRcZErqE1SW4VEBEWakCGW_yuXzda4rQ-xwXYBGYsP7w7SHN8CW9AyJwPMh6AYgMAPUWn7Zfof2z-KhnToNAc4fswEim5M5y-fXyOOXiMEwqGB-B-oIF9u74Js9kEGcrBtamYfZjW9j7cWxvGXsXx7UR5fwLxfho5nyX3MMOF4qtJzCP-2Ti2gdkb9mavrv-Sd9QXxXsVbFHDoM50NEc6GAOH2g0BhqNgXYNHY2BJmN4SC6Oj84PT7J48EbmuBR9ZqyzeSOMbAppGHNClYLbumbKOGVEVfPGGcW45XXFZDVnrmlkbmylEA8XRjwi07Zr3RNCS66q2hgJIlV5hQEorPTIRyFYrawoZkQN0tEx5guxnAa167EEEQSrUbCaMe0Fq-WMvBqkqcEn4kaXaV23utElz5G1SMzI4yBk_T1QtyDehYi_KJ7e_rXPyN3xn_OcTPsfK_cCAtO-ehntCj9Pzy5PfwNqH4DW |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Progress+in+Brain+Research&rft.au=Comings%2C+David+E.&rft.au=Blum%2C+Kenneth&rft.atitle=Reward+deficiency+syndrome%3A+genetic+aspects+of+behavioral+disorders&rft.date=2000-01-01&rft.pub=Elsevier+Science+%26+Technology&rft.isbn=9780444503329&rft.issn=0079-6123&rft.eissn=1875-7855&rft.volume=126&rft.spage=325&rft.epage=341&rft_id=info:doi/10.1016%2FS0079-6123%2800%2926022-6&rft.externalDocID=S0079612300260226 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0079-6123&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0079-6123&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0079-6123&client=summon |